Table 3.
Association between podoplanin expression and clinicopathological parameters for 110 oral squamous cell carcinoma
| Features | Number | Podoplanin expression level | P | |
|---|---|---|---|---|
|
| ||||
| Low positive | High positive | |||
| Age (years) | 0.231 | |||
| ≤ 59 | 48 | 20 | 28 | |
| > 59 | 62 | 19 | 43 | |
| Gender | 0.461 | |||
| Male | 63 | 23 | 40 | |
| Female | 47 | 14 | 33 | |
| Sites | 0.688 | |||
| buccal | 21 | 7 | 14 | |
| tongue | 43 | 13 | 30 | |
| gingival | 26 | 8 | 18 | |
| others | 20 | 9 | 11 | |
| Differentiation | 0.014 | |||
| well | 30 | 16 | 14 | |
| moderate | 29 | 10 | 19 | |
| poor | 51 | 11 | 40 | |
| T stage | 0.978 | |||
| T1 | 27 | 10 | 17 | |
| T2 | 43 | 14 | 29 | |
| T3 | 19 | 6 | 13 | |
| T4 | 21 | 7 | 14 | |
| pN stage | 0.029 | |||
| pN- | 67 | 28 | 39 | |
| pN+ | 43 | 9 | 34 | |